RBC Bearings heads into its August 7 fiscal Q1 report with the analyst community freshly tilting bullish — and options traders agreeing.
The most timely signal comes from the analyst desk. Raymond James upgraded RBC to Outperform yesterday, setting a $645 target, making it the most recent voice in a consensus that already leans constructive. Morgan Stanley and Truist both lifted targets in May — to $640 and $615 respectively — while the Street mean price target now sits at $629. That implies roughly 10% upside from the current price of $570. The direction of travel has been consistently upward across firms for the past several months, though the stock itself has given back ground: down 5.7% over the past month, and still off from the levels at which those targets were set, the gap between price and consensus has actually widened heading into the print.
Options positioning reinforces the bullish lean. Call demand has remained elevated relative to puts, with the put/call ratio at 0.47 — about 0.8 standard deviations below its 20-day average of 0.61. That continues the shift first flagged ahead of the July 31 release, when the ratio had dropped sharply from mid-July levels above 0.80. The borrow market adds nothing to the bear case: availability is effectively unlimited, cost to borrow is minimal at 0.37%, and short interest at 1.5% of the free float is too small to move the needle directionally.
The bull case rests on end-market breadth — aggregates, warehousing, food and beverage, semiconductors, and an infrastructure build-out tied to AI and data centers — plus the recently completed VACCO acquisition extending RBC's reach into the marine market. Bears don't dispute the quality of the franchise. Their concern is valuation: the stock trades at roughly 35x trailing earnings and nearly 25x EV/EBITDA, a premium that leaves limited margin for error if aerospace build rates disappoint or macro conditions soften. Both multiples have eased over the past 30 days as the share price has pulled back, but they remain stretched relative to industrial peers — most of which also fell on the week, with CAT down 8.3% and CMI off 4.6%, though GTES bucked the group with a 4% gain.
The earnings history adds a note of caution. The May print produced a one-day drop of nearly 10%, followed by a further 8.5% five-day decline — a reminder that even well-regarded industrial compounders can punish any stumble at elevated multiples. The August 7 report will therefore test whether the VACCO integration is tracking to plan and whether end-market demand is holding up well enough to justify the premium the Street is still willing to assign.
See the live data behind this article on ORTEX.
Open RBC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
